Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.

Duployez N, Marceau-Renaut A, Villenet C, Petit A, Rousseau A, Ng SWK, Paquet A, Gonzales F, Barthélémy A, Leprêtre F, Pottier N, Nelken B, Michel G, Baruchel A, Bertrand Y, Leverger G, Lapillonne H, Figeac M, Dick JE, Wang JCY, Preudhomme C, Cheok M.

Leukemia. 2019 Feb;33(2):348-357. doi: 10.1038/s41375-018-0227-5. Epub 2018 Aug 8.

PMID:
30089916
2.

Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia.

Bond J, Labis E, Marceau-Renaut A, Duployez N, Labopin M, Hypolite G, Michel G, Ducassou S, Boutroux H, Nelken B, Bertrand Y, Baruchel A, Petit A, Asnafi V, Leverger G, Preudhomme C, Macintyre E, Lapillonne H.

Leukemia. 2018 Aug;32(8):1878-1882. doi: 10.1038/s41375-018-0187-9. Epub 2018 Jun 27. No abstract available.

PMID:
29950694
3.

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

Bellanné-Chantelot C, Schmaltz-Panneau B, Marty C, Fenneteau O, Callebaut I, Clauin S, Docet A, Damaj GL, Leblanc T, Pellier I, Stoven C, Souquere S, Antony-Debré I, Beaupain B, Aladjidi N, Barlogis V, Bauduer F, Bensaid P, Boespflug-Tanguy O, Berger C, Bertrand Y, Carausu L, Fieschi C, Galambrun C, Schmidt A, Journel H, Mazingue F, Nelken B, Quah TC, Oksenhendler E, Ouachée M, Pasquet M, Saada V, Suarez F, Pierron G, Vainchenker W, Plo I, Donadieu J.

Blood. 2018 Sep 20;132(12):1318-1331. doi: 10.1182/blood-2017-12-820308. Epub 2018 Jun 18.

PMID:
29914977
4.

Genetic polymorphisms of Th2 interleukins, history of asthma or eczema and childhood acute lymphoid leukaemia: Findings from the ESCALE study (SFCE).

Bonaventure A, Orsi L, Rudant J, Goujon-Bellec S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Pasquet M, Michel G, Sirvent N, Chastagner P, Ducassou S, Thomas C, Besse C, Hémon D, Clavel J.

Cancer Epidemiol. 2018 Aug;55:96-103. doi: 10.1016/j.canep.2018.05.004. Epub 2018 Jun 6.

PMID:
29883839
5.

Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.

Perez M, Décaudin B, Abou Chahla W, Nelken B, Storme L, Masse M, Barthélémy C, Lebuffe G, Odou P.

Sci Rep. 2018 May 16;8(1):7714. doi: 10.1038/s41598-018-25602-6.

6.

Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE.

Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T, Libbrecht C, Michel G, Jeziorski E, Armari-Alla C, Nelken B, Pellier I, Pasquet M, Perel Y, Aladjidi N.

Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25137. [Epub ahead of print] No abstract available.

PMID:
29756344
7.

An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.

Kaspers GJL, Niewerth D, Wilhelm BAJ, Scholte-van Houtem P, Lopez-Yurda M, Berkhof J, Cloos J, de Haas V, Mathôt RA, Attarbaschi A, Baruchel A, de Bont ES, Fagioli F, Rössig C, Klingebiel T, De Moerloose B, Nelken B, Palumbo G, Reinhardt D, Rohrlich PS, Simon P, von Stackelberg A, Zwaan CM.

Br J Haematol. 2018 May;181(4):523-527. doi: 10.1111/bjh.15233. Epub 2018 Apr 20.

PMID:
29676440
8.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Gauthier J, Poiré X, Gac AC, Leclerc M, Guillaume T, Chalandon Y, Nguyen S, Forcade E, Régny C, Bay JO, Bazarbachi A, Rohrlich PS, Huynh A, Farhi J, Marchand T, Malfuson JV, Pilorge S, Labussière-Wallet H, Renard C, Fornecker LM, Detrait M, Duléry R, Delage J, Ménard AL, Charbonnier A, Nelken B, Jubert C, Suarez F, de la Tour RP, Beguin Y, Schoemans H, Blaise D, Yakoub-Agha I.

Bone Marrow Transplant. 2018 Apr;53(4):400-409. doi: 10.1038/s41409-017-0018-z. Epub 2018 Jan 12.

9.

Better early outcome with enteral rather than parenteral nutrition in children undergoing MAC allo-SCT.

Gonzales F, Bruno B, Alarcón Fuentes M, De Berranger E, Guimber D, Behal H, Gandemer V, Spiegel A, Sirvent A, Yakoub-Agha I, Nelken B, Duhamel A, Seguy D.

Clin Nutr. 2018 Dec;37(6 Pt A):2113-2121. doi: 10.1016/j.clnu.2017.10.005. Epub 2017 Oct 12.

PMID:
29097037
10.

Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia.

Duployez N, Abou Chahla W, Lejeune S, Marceau-Renaut A, Letizia G, Boyer T, Geffroy S, Peyrouze P, Grardel N, Nelken B, Michel G, Bertrand Y, Preudhomme C.

Eur J Haematol. 2018 Jan;100(1):104-107. doi: 10.1111/ejh.12981. Epub 2017 Nov 9. Review.

PMID:
29034503
11.

Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.

Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, Nelken B, Monpoux F, Guitton C, Leblanc T, Fisher A, Lejars O, Jeziorski E, Fouissac F, Lutz P, Pasquet M, Pellier I, Piguet C, Vic P, Bayart S, Marie-Cardine A, Michel M, Perel Y, Aladjidi N.

Br J Haematol. 2017 Jun;177(5):751-758. doi: 10.1111/bjh.14627. Epub 2017 Apr 26.

PMID:
28444729
12.

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

Roux C, Tifratene K, Socié G, Galambrun C, Bertrand Y, Rialland F, Jubert C, Pochon C, Paillard C, Sirvent A, Nelken B, Vannier JP, Freycon C, Beguin Y, Raus N, Yakoub-Agha I, Mohty M, Dalle JH, Michel G, Pradier C, Peffault de Latour R, Rohrlich PS.

Bone Marrow Transplant. 2017 May;52(5):678-682. doi: 10.1038/bmt.2016.360. Epub 2017 Jan 23.

13.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.

Alloin AL, Leverger G, Dalle JH, Galambrun C, Bertrand Y, Baruchel A, Auvrignon A, Gandemer V, Ragu C, Loundou A, Bilhou-Nabera C, Lafage-Pochitaloff M, Dastugue N, Nelken B, Jubert C, Rialland F, Plat G, Pochon C, Vannier JP, Rohrlich PS, Kanold J, Lutz P, Sirvent A, Oudin C, Cuccuini W, Michel G.

Bone Marrow Transplant. 2017 Apr;52(4):516-521. doi: 10.1038/bmt.2016.293. Epub 2016 Dec 12.

PMID:
27941778
14.

NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.

Duployez N, Grzych G, Ducourneau B, Alarcon Fuentes M, Grardel N, Boyer T, Abou Chahla W, Bruno B, Nelken B, Clappier E, Preudhomme C.

Haematologica. 2016 Apr;101(4):e133-4. doi: 10.3324/haematol.2015.136499. Epub 2015 Dec 17. No abstract available.

15.

Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children.

Tiphaine Ade B, Hjalgrim LL, Nersting J, Breitkreutz J, Nelken B, Schrappe M, Stanulla M, Thomas C, Bertrand Y, Leverger G, Baruchel A, Schmiegelow K, Jacqz-Aigrain E.

Eur J Pharm Sci. 2016 Feb 15;83:1-7. doi: 10.1016/j.ejps.2015.12.002. Epub 2015 Dec 2.

PMID:
26657824
16.

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.

Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, Lainey E, Nouri K, Nakhaei-Rad S, Dvorsky R, Lachenaud J, Pereira S, Vivent J, Verger E, Vidaud D, Galambrun C, Picard C, Petit A, Contet A, Poirée M, Sirvent N, Méchinaud F, Adjaoud D, Paillard C, Nelken B, Reguerre Y, Bertrand Y, Häussinger D, Dalle JH, Ahmadian MR, Baruchel A, Chomienne C, Cavé H.

Nat Genet. 2015 Nov;47(11):1334-40. doi: 10.1038/ng.3420. Epub 2015 Oct 12.

PMID:
26457648
17.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).

Nelken B, Cave H, Leverger G, Galambrun C, Plat G, Schmitt C, Thomas C, Vérité C, Brethon B, Gandemer V, Bertrand Y, Baruchel A, Rohrlich P.

Pediatr Blood Cancer. 2016 Feb;63(2):270-5. doi: 10.1002/pbc.25751. Epub 2015 Sep 16.

PMID:
26376115
18.

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.

Antony-Debré I, Duployez N, Bucci M, Geffroy S, Micol JB, Renneville A, Boissel N, Dhédin N, Réa D, Nelken B, Berthon C, Leblanc T, Mozziconacci MJ, Favier R, Heller PG, Abdel-Wahab O, Raslova H, Latger-Cannard V, Preudhomme C.

Leukemia. 2016 Apr;30(4):999-1002. doi: 10.1038/leu.2015.236. Epub 2015 Aug 28. No abstract available.

PMID:
26316320
19.

Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study.

Orsi L, Rudant J, Ajrouche R, Leverger G, Baruchel A, Nelken B, Pasquet M, Michel G, Bertrand Y, Ducassou S, Gandemer V, Lutz P, Saumet L, Moreau P, Hemon D, Clavel J.

Cancer Causes Control. 2015 Jul;26(7):1003-17. doi: 10.1007/s10552-015-0593-5. Epub 2015 May 9.

PMID:
25956268
20.

ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.

Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Baruchel A, Petit A, Bertrand Y, Nelken B, Pasquet M, Michel G, Saumet L, Chastagner P, Ducassou S, Réguerre Y, Hémon D, Clavel J.

PLoS One. 2015 Mar 25;10(3):e0121348. doi: 10.1371/journal.pone.0121348. eCollection 2015.

21.

In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets.

Perez M, Décaudin B, Abou Chahla W, Nelken B, Barthélémy C, Lebuffe G, Odou P.

Pediatr Blood Cancer. 2015 Jun;62(6):1042-7. doi: 10.1002/pbc.25442. Epub 2015 Mar 8.

PMID:
25755136
22.

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.

Pochon C, Oger E, Michel G, Dalle JH, Salmon A, Nelken B, Bertrand Y, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rohrlich P, Paillard C, Demeocq F, Schneider P, Plantaz D, Poirée M, Eliaou JF, Semana G, Drunat S, Jonveaux P, Bordigoni P, Gandemer V.

Br J Haematol. 2015 Apr;169(2):249-61. doi: 10.1111/bjh.13272. Epub 2014 Dec 19.

PMID:
25522886
23.

[Superior vena cava thrombosis in patients with mediastinal large B-cell lymphoma: two pediatric cases].

Gonzales F, Abou Chahla W, Pagniez J, Nelken B.

Arch Pediatr. 2015 Jan;22(1):66-70. doi: 10.1016/j.arcped.2014.08.022. Epub 2014 Sep 26. French.

PMID:
25267192
24.

Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance.

Letouzey M, Penther D, Roche-Lestienne C, Nelken B, Devoldère C, Vannier JP, Schneider P.

Ann Hematol. 2015 Feb;94(2):187-93. doi: 10.1007/s00277-014-2204-z. Epub 2014 Sep 6.

PMID:
25193356
25.

Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.

Guerriero E, Simon N, Nelken B, Baldeyrou B, Djobo B, Vasseur M, Allorge D, Décaudin B, Odou P.

Ther Drug Monit. 2014 Aug;36(4):499-504. doi: 10.1097/FTD.0000000000000053.

PMID:
25014075
26.

Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE study.

Ajrouche R, Rudant J, Orsi L, Petit A, Baruchel A, Nelken B, Pasquet M, Michel G, Bergeron C, Ducassou S, Gandemer V, Lutz P, Saumet L, Rialland X, Hémon D, Clavel J.

Cancer Causes Control. 2014 Oct;25(10):1283-93. doi: 10.1007/s10552-014-0429-8. Epub 2014 Jul 11.

PMID:
25011403
27.

Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.

Lervat C, Auperin A, Patte C, Méchinaud F, Leverger G, Nelken B, Bertrand Y, Baruchel A, Coze C, Munzer M, Lacombe MJ, Bergeron C.

Pediatr Blood Cancer. 2014 Mar;61(3):473-8. doi: 10.1002/pbc.24707. Epub 2013 Aug 23.

PMID:
23970385
28.

[Steroid intake before leukemia diagnosis impairs outcome in childhood acute lymphoblastic leukemia].

Gatineau-Sailliant S, Buchbinder N, Callat MP, Nelken B, Pautard B, Vannier JP, Schneider P.

Arch Pediatr. 2013 Apr;20(4):341-7. doi: 10.1016/j.arcped.2013.01.016. Epub 2013 Feb 21. French.

PMID:
23433842
29.

Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms.

Bonaventure A, Rudant J, Goujon-Bellec S, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Pasquet M, Michel G, Sirvent N, Bordigoni P, Ducassou S, Rialland X, Zelenika D, Hémon D, Clavel J.

Cancer Causes Control. 2013 Apr;24(4):783-93. doi: 10.1007/s10552-013-0161-9. Epub 2013 Feb 13. Erratum in: Cancer Causes Control. 2014 Aug;25(8):1081.

PMID:
23404349
30.

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.

Dastugue N, Suciu S, Plat G, Speleman F, Cavé H, Girard S, Bakkus M, Pagès MP, Yakouben K, Nelken B, Uyttebroeck A, Gervais C, Lutz P, Teixeira MR, Heimann P, Ferster A, Rohrlich P, Collonge MA, Munzer M, Luquet I, Boutard P, Sirvent N, Karrasch M, Bertrand Y, Benoit Y.

Blood. 2013 Mar 28;121(13):2415-23. doi: 10.1182/blood-2012-06-437681. Epub 2013 Jan 15.

31.

French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.

Trioche P, Nelken B, Michel G, Pellier I, Petit A, Bertrand Y, Rohrlich P, Schmitt C, Sirvent N, Boutard P, Margueritte G, Pautard B, Ducassou S, Plantaz D, Robert A, Thomas C, Desseaux K, Chevret S, Baruchel A.

Exp Hematol Oncol. 2012 Dec 10;1(1):39. doi: 10.1186/2162-3619-1-39.

32.

Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)?

Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Corda E, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Sirvent N, Chastagner P, Ducassou S, Rialland X, Hémon D, Leverger G, Clavel J.

Leukemia. 2013 Mar;27(3):746-8. doi: 10.1038/leu.2012.244. Epub 2012 Aug 27. No abstract available.

PMID:
22922568
33.

Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis.

Cornet E, Dumézy F, Roumier C, Lepelley P, Jouy N, Philippe N, Renneville A, Berthon C, Nelken B, Quesnel B, Preudhomme C.

Leuk Res. 2012 Nov;36(11):1330-3. doi: 10.1016/j.leukres.2012.07.001. Epub 2012 Aug 4.

PMID:
22871474
34.

Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE).

Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G, Haouy S, Chastagner P, Ducassou S, Rialland X, Hémon D, Clavel J.

Cancer Causes Control. 2012 Aug;23(8):1265-77. doi: 10.1007/s10552-012-0004-0. Epub 2012 Jun 16.

PMID:
22706675
35.

Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE).

Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, Evans TJ, Petit A, Bertrand Y, Nelken B, Robert A, Michel G, Sirvent N, Chastagner P, Ducassou S, Rialland X, Hémon D, Milne E, Scott RJ, Baruchel A, Clavel J.

Leukemia. 2012 Dec;26(12):2561-4. doi: 10.1038/leu.2012.148. Epub 2012 Jun 4. No abstract available.

PMID:
22660188
36.

Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE).

Rudant J, Amigou A, Orsi L, Althaus T, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G, Sirvent N, Chastagner P, Ducassou S, Rialland X, Hémon D, Clavel J.

Pediatr Blood Cancer. 2013 Feb;60(2):301-8. doi: 10.1002/pbc.24192. Epub 2012 May 18.

PMID:
22610722
37.

Enteral nutrition: a first option for nutritional support of children following allo-SCT?

Azarnoush S, Bruno B, Beghin L, Guimber D, Nelken B, Yakoub-Agha I, Seguy D.

Bone Marrow Transplant. 2012 Sep;47(9):1191-5. doi: 10.1038/bmt.2011.248. Epub 2012 Jan 9.

PMID:
22231466
38.

Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE).

Bonaventure A, Goujon-Bellec S, Rudant J, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Pasquet M, Michel G, Sirvent N, Bordigoni P, Ducassou S, Rialland X, Zelenika D, Hémon D, Clavel J.

Cancer Causes Control. 2012 Feb;23(2):329-45. doi: 10.1007/s10552-011-9882-9. Epub 2011 Dec 27.

PMID:
22200898
39.

New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE).

Haematologica. 2011 May;96(5):655-63. doi: 10.3324/haematol.2010.036053. Epub 2011 Jan 12.

40.

Road traffic and childhood leukemia: the ESCALE study (SFCE).

Amigou A, Sermage-Faure C, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Mechinaud F, Bordigoni P, Hémon D, Clavel J.

Environ Health Perspect. 2011 Apr;119(4):566-72. doi: 10.1289/ehp.1002429. Epub 2010 Dec 8.

41.

Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881.

Sirvent N, Suciu S, Rialland X, Millot F, Benoit Y, Plantaz D, Ferster A, Robert A, Lutz P, Nelken B, Plouvier E, Norton L, Bertrand Y, Otten J.

Eur J Cancer. 2011 Jan;47(2):239-47. doi: 10.1016/j.ejca.2010.10.019. Epub 2010 Nov 20.

PMID:
21095115
42.

Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies.

Renneville A, Kaltenbach S, Clappier E, Collette S, Micol JB, Nelken B, Lepelley P, Dastugue N, Benoît Y, Bertrand Y, Preudhomme C, Cavé H.

Leukemia. 2010 Feb;24(2):476-80. doi: 10.1038/leu.2009.221. Epub 2009 Oct 22. No abstract available.

PMID:
19847202
43.

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.

Brugières L, Pacquement H, Le Deley MC, Leverger G, Lutz P, Paillard C, Baruchel A, Frappaz D, Nelken B, Lamant L, Patte C.

J Clin Oncol. 2009 Oct 20;27(30):5056-61. doi: 10.1200/JCO.2008.20.1764. Epub 2009 Sep 8.

PMID:
19738127
44.

Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE).

Brosselin P, Rudant J, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Mechinaud F, Bordigoni P, Hémon D, Clavel J.

Occup Environ Med. 2009 Sep;66(9):598-606. doi: 10.1136/oem.2008.042432. Epub 2009 Feb 12.

PMID:
19213757
45.

Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia.

Brethon B, Yakouben K, Oudot C, Boutard P, Bruno B, Jérome C, Nelken B, de Lumley L, Bertrand Y, Dalle JH, Chevret S, Leblanc T, Baruchel A.

Br J Haematol. 2008 Nov;143(4):541-7. doi: 10.1111/j.1365-2141.2008.07370.x. Epub 2008 Aug 28.

PMID:
18759760
46.

[Cord blood collection for potential stem cell transplantation to a family member: the long-term experience of a level-III maternity unit].

Gascard C, Boulanger F, Lambiliotte A, Depret S, Nelken B, Royez-Brovelli M, Mazingue F, Jouet JP, Subtil D.

Presse Med. 2008 Dec;37(12):1731-8. doi: 10.1016/j.lpm.2007.12.015. Epub 2008 Jul 24. French.

PMID:
18656324
47.

SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.

Bertrand Y, Mechinaud F, Brethon B, Mialou V, Auvrignon A, Nelken B, Notz-Carrère A, Plantaz D, Patte C, Urbieta M, Baruchel A, Leverger G; SFCE.

J Pediatr Hematol Oncol. 2008 Apr;30(4):267-71. doi: 10.1097/MPH.0b013e318162bd41.

PMID:
18391694
48.

Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE).

Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y, Patte C, Pacquement H, Vérité C, Robert A, Michel G, Margueritte G, Gandemer V, Hémon D, Clavel J.

Environ Health Perspect. 2007 Dec;115(12):1787-93.

49.

Rituximab therapy for childhood Evans syndrome.

Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, Armari-Alla C, Picard C, Ledeist F, Munzer M, Yacouben K, Bertrand Y, Pariente A, Chaussé A, Perel Y, Leverger G.

Haematologica. 2007 Dec;92(12):1691-4.

50.

Subdural effusion in a CNS involvement of systemic juvenile xanthogranuloma: a case report treated with vinblastin.

Auvin S, Cuvellier JC, Vinchon M, Defoort-Dhellemes S, Soto-Ares G, Nelken B, Vallée L.

Brain Dev. 2008 Feb;30(2):164-8. Epub 2007 Aug 27.

PMID:
17720345

Supplemental Content

Loading ...
Support Center